Cat.#: ACPP-1638
Despition | CNTF Human Recombinant |
SIZE | 5 µg |
Sequence | Met-Ala-Phe-Thr-Glu. |
Purity | > 98.0% (SDS-PAGE) |
Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
Storage | Lyophilized was stored and desiccated below -18°C. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1210 | Alpha SNAP Blocking Peptide (AC1210) | 250 µg | inquiry |
ACPP-1574 | Human NDUFS4 Protein (AC1574) | 5 µg | inquiry |
ACPP-1086 | Synthetic Nanodisc Human Somatostatin Receptor 2 Protein (AC1086) | 10 µg | inquiry |
ACPP-1678 | Human SDCBP Protein (AC1678) | 5 µg | inquiry |
ACPP-1744 | Human C1q Protein (AC1744) | 200 µg | inquiry |
ACPP-1318 | Orexin A Blocking Peptide (AC1318) | 250 µg | inquiry |
ACPP-1569 | Human SOX2 Protein (AC1569) | 5 µg | inquiry |
ACPP-1142 | Recombinant Human TrkC Protein (Fc Tag) (AC1142) | 50 µg | inquiry |
ACPP-1217 | P2Y2 Blocking Peptide (AC1217) | 250 µg | inquiry |
ACPP-1536 | Human EFNB1 Protein (AC1536) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.